Covestor’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Covestor's IBRX Position: Q3 2026 in Review
Covestor reduced its ImmunityBio (IBRX) stake by 5.2% in Q3 2026, selling an estimated $472 and leaving 1,074 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1457.
Covestor first reported a position in IBRX in Q4 2021 and has held it in 20 quarters since. 123 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Covestor held 1,074 shares of ImmunityBio worth $10K as of Q3 2026.
- Covestor sold 59 ImmunityBio shares in Q3 2026, an estimated $472.
- ImmunityBio made up 0.01% of Covestor's portfolio in Q3 2026, its #1457 holding.
- Covestor first reported a position in ImmunityBio in Q4 2021 and has held it in 20 quarters since.
- 123 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.